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Surgical Management of Infective Endocarditis Complicated by 
Embolic Stroke: Early versus Delayed Surgery
Gwan  Sic  Kim,  M.D.*,  Joon  Bum  Kim,  M.D.*,  Sung-Ho  Jung,  M.D.*,  Tae-Jin  Yun,  M.D.*, 
Suk  Jung  Choo,  M.D.*,  Cheol  Hyun  Chung,  M.D.*,  Jae  Won  Lee,  M.D.*
Background:  The optimal timing of surgery for infective endocarditis complicated by embolic stroke is unclear. We 
compared early versus delayed surgery in these patients. Materials and Methods: Between 1992 and 2007, 56 
consecutive patients underwent open cardiac surgery for the treatment of infective endocarditis complicated by acute 
septic embolic stroke, 34 within 2 weeks (early group) and 22 more than 2 weeks (delayed group) after the onset 
of stroke. Results: The mean age at time of surgery was 45.7±14.8 years. Stroke was ischemic in 42 patients 
and hemorrhagic in 14. Patients in the early group were more likely to have highly mobile, large (＞1 cm in di-
ameter) vegetation and less likely to have hemorrhagic infarction than those in the delayed group. There were two 
(3.7%) intraoperative deaths, both in the early group and attributed to neurologic aggravation. Among the 54 survi-
vors, 4 (7.1%), that is, 2 in each group, showed neurologic aggravation. During a median follow-up of 61.7 mon-
ths (range, 0.4∼170.4 months), there were 5 late deaths. Overall 5-year neurologic aggravation-free survival rates 
were 79.1±7.0% in the early group and 90.9±6.1% in the delayed group (p=0.113). Conclusion: Outcomes of early 
operation for infective endocarditis in stroke patients were similar to those of the conventional approach. Early sur-
gical intervention may be preferable for patients at high risk of life-threatening septic embolism.
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INTRODUCTION
Although  optimal  medical  management  consists  of  anti-
microbial medications, about 20% to 40% of patients with in-
fective  endocarditis  (IE)  experience  neurologic  complications 
[1-4].  The  most  common  of  these  complications,  septic  em-
bolic  stroke  due  to  endocardial  vegetation,  is  associated  with 
a  high  mortality  rate  and  poor  prognosis  [5].  Although  early 
surgery in patients with IE plus septic embolic stroke may re-
duce  the  risk  of  further  embolic  episodes  by  eliminating  its 
sources,  cardiopulmonary  bypass  during  the  acute  phase  of 
neurologic  events  may  exacerbate  neurologic  symptoms  in 
these  patients.  It  has  been  recommended  that  cardiac  surgery 
for these patients be deferred until after 2 to 4 weeks of opti-
mal  medical  treatment  [6,7].  However,  the  proper  timing  of 
cardiac  surgery  in  this  setting  remains  unclear.  We  therefore Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Early versus Delayed Surgery
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evaluated  patient  outcomes  relative  to  the  timing  of  surgery 
for  IE  in  patients  with  acute  embolic  stroke.  We  compared 
the  composite  endpoint  of  death  and  neurologic  aggravation 
in  patients  who  underwent  early  surgery  (within  2  weeks  of 
stroke  onset)  and  delayed  surgery  (after  2  weeks).
MATERIALS AND METHODS
From January 1992 to December 2007, 317 consecutive pa-
tients underwent open cardiac surgery for the treatment of IE 
in  our  institution.  The  diagnosis  of  IE  was  based  on  the 
modified Duke criteria [8]. Of these, 56 patients had IE com-
plicated  by  acute  septic  embolic  stroke  at  the  time  of 
presentation.  Signs  of  acute  embolic  stroke  included  cerebral 
infarction  and  cerebral  hemorrhage.  Patients  were  evaluated 
neurologically  or  by  brain  imaging,  including  magnetic  reso-
nance  imaging  (MRI)  in  51  patients  (91.1%)  and  computed 
tomography  (CT)  in  5  (8.9%). 
Of the 56 patients included, 34 underwent surgery within 2 
weeks after the onset of stroke (early group), whereas surgery 
was deferred until after 2 weeks in the remaining 22 patients 
(delayed group). This study was approved by our institutional 
review  board,  which  waived  informed  consent  owing  to  the 
retrospective  nature  of  this  study.
1) Surgical techniques
A median sternotomy approach and conventional ascending 
aorta  and  bicaval  cannulation  were  the  usual  strategy. 
Myocardial protection was achieved with antegrade and retro-
grade  tepid  blood  cardioplegia.  When  infective  endocarditis 
involved  the  aortic  valve,  the  valve  or  root  was  replaced. 
When the mitral valve was involved, the decision to repair or 
replace  was  determined  according  to  the  degree  of  mitral  ap-
paratus preservation after resection of the infected tissue; that 
is,  mitral  valve  replacement  was  performed  only  when  the 
mitral tissue remaining after resection did not allow for repair 
surgery.
2) Postoperative management
Intravenous antimicrobial medications were continued for at 
least 4 weeks after surgery. If blood culture after surgery was 
positive  for  bacterial  growth,  intravenous  antimicrobial  medi-
cations  were  continued  for  at  least  4  weeks  after  culture 
negativity. Antimicrobial regimens were continued or adjusted 
according to the results of bacterial culture and drug suscepti-
bility  of  operative  specimens.  If  no  microorganism  was  cul-
tured  from  either  the  blood  or  surgical  specimens,  called 
“culture-negative  endocarditis”,  then  the  patient  was  treated 
with  consultation  with  an  infectious  diseases  specialist  and 
the  total  duration  of  therapy  was  4  to  6  weeks  or  more.
Patients  who  underwent  valve  repair  or  bioprosthetic  valve 
implantation  were  routinely  administered  warfarin  for  3∼6 
months  postoperatively,  with  a  target  international  normalized 
ratio (INR) of 1.5∼2.5. Further anticoagulation was based on 
the presence of thromboembolic risks and cardiac rhythm sta-
tus  in  each  patient.  For  patients  with  mechanical  valve  im-
plantation, the target INR was 2.0∼3.0, regardless of cardiac 
rhythm  status.
3) Definitions
The  primary  endpoint  of  this  study  was  defined  as  the 
composite  of  death  and  neurological  aggravation,  as  de-
termined  clinically  by  neurologists,  after  surgery.  The  secon-
dary  endpoint  was  defined  as  the  worsening  of  brain  injury 
on  CT  and/or  MRI.  Worsening  of  injury  included  hemor-
rhagic conversion of ischemic infarction, increased size of in-
farction  or  hemorrhage,  and  development  of  new  lesions.
4) Statistical analysis
Categorical  variables  are  presented  as  frequencies  and  per-
centages, and continuous variables are expressed as mean±SD 
or  medians  and  ranges.  Differences  in  baseline  characteristics 
between  the  early  and  delayed  groups  were  compared  using 
the  t-test  or  the  Mann-Whitney  U  test  for  continuous  varia-
bles  and  the  chi-square  test  or  Fisher’s  exact  test  for  catego-
rical  variables,  as  appropriate.  Cumulative  incidence  rates  of 
the composite outcome were estimated using the Kaplan-Meier 
method  and  compared  using  the  log-rank  test.  All  reported 
p-values  are  two-sided,  and  p＜0.05  was  considered  statisti-
cally  significant.  Data  documentation  and  statistical  analysis 
were  performed  with  SPSS  16.0  (SPSS  Inc.). Gwan Sic Kim, et al
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Table 1. Baseline characteristics of all patients
Early  surgery  (＜14  days) Delayed  surgery  (≥14  days) p-value
Number  of  patients
Age  (years)
Male,  n  (%)
N Y H A  f u n c t i o n a l  c l a s s ,  n  ( % )
  I
  I I
  I I I
  I V
Ejection  fraction  (%)
Predisposing  factors,  n  (%)
    Previous  endocarditis
    Bicuspid  aortic  valve
    Prosthetic  heart  valve
Underlying  condition
    Diabetes  mellitus,  n  (%)
    Hypertension,  n  (%)
Infected  valve,  n  (%)
  A o r t i c
  M i t r a l
  A o r t i c  a n d  m i t r a l
Neurologic  complication,  n  (%)
    Cerebral  infarction
    Cerebral  hemorrhage
M o b i l e  l a r g e  v e g e t a t i o n ,  n  ( % )
Laboratory  test
  W B C
  C R P
    Creatinine
Elective  operation,  n  (%)
34
  43.5±13.9
23  (67.6)
25  (73.5)
  6  (17.6)
2  (5.9)
1  (2.9)
58.7±8.0
3  (8.8)
 0
1  (2.9) 
3  (8.8)
  8  (23.5)
12  (35.3)
18  (52.9)
  4  (11.7)
29  (85.3)
  5  (14.7)
34  (100)
11,867.1±8,124.2
 8 . 0 ±6.9
 1 . 2 ±0.7
26  (76.5)
22
  49.0±15.9
14  (63.6)
13  (59.1)
  4  (18.2)
  5  (22.7)
 0
55.8±1.6
1  (4.5)
  3  (13.6)
  6  (27.3)
  3  (13.6)
  5  (22.7)
  6  (27.3)
12  (54.5)
  4  (18.2)
13  (59.1)
  9  (40.9)
11  (50)
  8,820.9±3,664.3
 9 . 3 ±8.3
 1 . 0 ±0.4
19  (86.4)
0.17 
0.76
0.22
0.26 
0.001*
0.67 
0.95 
0.75
0.027* 
＜0.001*
0.11 
0.51 
0.31 
0.079
*p＜0.05.
RESULTS
1) Demographic and clinical features
Of  the  56  patients,  37  (66.1%)  were  male;  mean  age  at 
surgery  was  45.7±14.8  years.  According  to  modified  Duke 
criteria,  43 patients  (76.8%) had  definite  and  13 (23.2%)  had 
possible  infective  endocarditis,  with  the  latter  meeting  1  ma-
jor and ＜3 minor criteria. Of these patients, 42 (75.0%) had 
ischemic  and  14  (25.0%)  had  hemorrhagic  events.  The  base-
line  characteristics  of  the  pat i e n t s  a r e  s h o w n  i n  T a b l e  1 .  
Patients  in  the  early  group  were  more  likely  to  have  large 
(＞1 cm) mobile vegetation, and were less likely to have un-
dergone prosthetic valve implantation and have  cerebral  hem-
orrhage,  than  those  in  the  delayed  group.
2) Preoperative neurological manifestations and mic-
roorganisms
Acute  embolic  infarction  was  observed  in  26  patients,  pro-
ducing  neurologic  symptoms  of  dysarthria  (n=6),  sensory  or 
motor loss (n=5), drowsiness (n=5), aphasia (n=3), visual loss 
(n=2),  disorientation  (n=2),  memory  impairment  (n=1),  dizzi-
ness  (n=1),  and  syncope  (n=1).  Eleven  patients  had  acute 
hemorrhage,  presenting  with  symptoms  of  drowsiness  (n=9), 
severe  headache  (n=1),  and  seizure  (n=1).  The  remaining  19 
patients  had  no  symptoms  of  neurologic  complications.
Multiple  microemboli  occurred  in  12  (21.4%)  patients,  and 
intracranial  mycotic  aneurysms  i n  3  ( 5 . 4 % ) .  O n e  p a t i e n t  
(1.8%)  had  multiple  brain  abscesses  caused  by  Staphylococ-Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Early versus Delayed Surgery
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Table 2. Postoperative clinical and imaging evaluation of patient 
neurologic status
Early 
surgery
Delayed 
surgery
p-value
Clinical  evaluation,  n  (%)
  I m p r o v e d
    No  change 
    Aggravated 
Imaging  evaluation,  n  (%)
  N u m b e r  o f  p a t i e n t s
   e v a l u a t e d
    B e t t e r  
    N o  c h a n g e  
    W o r s e  
34
26  (76.5%)
 4  ( 1 1 . 8 % )
 4  ( 1 1 . 8 % )
18  (52.9%)
 5  ( 2 7 . 8 % )
 7  ( 3 8 . 9 % )
 6  ( 3 3 . 3 % )
22
18  (81.8%)
2  (9.1%)
2  (9.1%)
14  (63.6%)
 6  ( 4 2 . 9 % )
 4  ( 2 8 . 6 % )
 4  ( 2 8 . 6 % )
＞0.99
0.742
Fig. 1. Neurologic aggravation-free survival rate.
cus  aureus.
Microorganisms  responsible  for  IE  included  Streptococcus 
in  20  patients  (35.7%),  Staphylococcus  in  12  (21.4%),  the 
HACEK  group  in  3  (5.4%,  including  Haemophilus  in  1  and 
Cardiobacterium  in  2),  fungus  in  1  (1.8%),  and  others  in  5 
(8.9%,  including  Enterococcus  in  2,  Klebsiella  in  1,  Brucella 
in 1, and Gamella in 1). The causative microorganisms could 
not  be  determined  in  15  patients  (26.8%).
3) Perioperative data and operative outcomes
The  mean  times  from  onset  of  acute  septic  embolic  stroke 
to  time  of  surgery  were  3  days  (range,  0∼12  days)  in  the 
early  surgery  group and  20 days (range, 14∼69 days) in the 
delayed surgery group. Aortic cross clamping time (88.2±59.4 
min vs 80.0±37.8 min, p=0.568) and cardiopulmonary bypass 
time  (124.6±8 3 . 4  m i n  v s  1 2 1 . 8 ±51.6  min,  p=0.891)  were 
similar  in  the  early  and  delayed  groups.  Surgical  procedures 
included isolated mitral valve replacement in 22 patients, iso-
lated  mitral  valve  repair  in  8,  isolated  aortic  valve  replace-
ment  in  15,  combined  aortic  valve  replacement  and  mitral 
valve  replacement  in  8,  and  Bentall  operation  in  3.  There 
were two early deaths in the early surgery group (3.7%), with 
one  patient  dying  11  days  after  surgery  due  to  a  cerebral 
hemorrhage, and another dying 18 days after surgery due to a 
cerebral  infarction.
Among  the  54  survivors,  4  (7.1%)  showed  neurologic  ag-
gravation  on  clinical  evaluations,  2  each  in  the  early  and  de-
layed  groups.  Follow-up  brain  imaging  was  performed  in  32 
patients (57.1%). Changes in the postoperative neurologic sta-
tus  at  discharge  are  summarized  in  Table  2.  There  were  no 
significant  differences  in  neurologic  aggravation  between  the 
two  groups,  either  clinically  or  radiologically.
During  a  median  follow-up  of  61.7  months  (range,  0.4∼
170.4  months),  there  were  five  late  deaths,  all  in  the  early 
surgery  group.  Causes  of  late  deaths  were  cerebral  hemor-
rhage in one patient, unknown in one, and non-cardiac-related 
events in three (one each from a traffic accident, aplastic ane-
mia,  and  common  bile  duct  cancer).
The  overall  mean  5-year  neurologic  aggravation-free  sur-
vival rates were 79.1±7.0% in the early group and 90.9±6.1% 
in  the  delayed  group  (p=0.113)  (Fig.  1).
DISCUSSION
Our  results  indicated  that  early  and  delayed  surgical  inter-
v e n t i o n s  f o r  I E  w e r e  a s s o c i a t e d  w i t h  s i m i l a r  s u r v i v a l  a n d  
neurologic  function  in  patients  with  acute  septic  embolic 
stroke.  Neurologic  deterioration  was  not  influenced  by  the 
t i m e  i n t e r v a l  f r o m  o n s e t  o f  a c u t e  s e p t i c  e m b o l i c  s t r o k e  t o  
time  of  surgery.  Although  two  patients  in  the  early  operation 
group  died  soon  after  surgery,  at  11  and  18  days,  the  differ-
ence  between  the  two  groups  was  not  statistically  significant. 
Most patients with acute embolic stroke completely recovered 
from  their  neurologic  symptoms  without  aggravation  of  neu-
rologic  imaging  status.
Heparin anticoagulation during  cardiopulmonary  bypass has Gwan Sic Kim, et al
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been regarded as at risk for secondary bleeding into ischemic 
regions,  and  low-pressure,  non-pulsatile  blood  flow  may  ac-
centuate  the  development  of  ischemic  edema  in  the  injured 
brain  tissue  [9].  After  cerebral  infarction,  autoregulation  of 
blood  flow  to  the  infarcted  area  is  lost  for  4∼5  weeks. 
During  this  period,  tissue  perfusion  is  directly  related  to 
blood  pressure  and  even  a  slight  change  of  blood  pressure 
can  result  in  infarct  extension  and  neurological  deterioration 
[10].  These  observations  have  led  to  suggestions  that  cardiac 
surgery  be  delayed  until  after  the  recovery  of  cerebral  blood 
flow  autoregulation,  a  period  of  2  weeks  after  an  ischemic 
stroke  and  4  weeks  after  a  hemorrhagic  stroke  [5,6].  Alth-
ough there has been some evidence that supports this conven-
tional  management  strategy  [11,12],  there  have  been  no  clin-
ical  studies  to  date  in  support of  this  delayed  strategy  for  IE 
in  patients  with  acute  stroke  [6].  We  found  that  surgical  in-
tervention  within  2  weeks  is  safe  in  IE  patients  with  acute 
septic  embolic  stroke,  and  associated  with  outcomes  similar 
to  those  of  delayed  surgery.
Despite  advances  in  antibiotic  treatment,  this  treatment 
alone  cannot  prevent  the  formation  of  mycotic  aneurysms 
caused  by  septic  emboli  and  does  not  decrease  the  incidence 
of  neurologic  complications  in  the  overall  IE  patient  pop-
ulation  [2,13,14].  Because  vegetations  of  IE  are  friable,  re-
moval  of  a  potential  source  of  emboli  can  prevent  embolic 
stroke  [3].  Patients  with  a  vegetation  with  a  diameter  greater 
t h a n  1  c m  a n d  h i g h  m o b i l i t y  h a v e  a  significantly  higher  in-
cidence of embolization, so that removal of the septic vegeta-
tion by early surgical intervention was effective in decreasing 
embolization  in  IE  patients  with  large  mobile  vegetations 
[15-17].  However,  the  optimal  timing  of  surgical  intervention 
in  IE  patients  with  acute  septic  embolic  stroke  has  remained 
unclear.  Although  early  surgical  intervention  was  previously 
shown  to  be  safe  in  15  IE  patients  with  recent  cardiogenic 
embolic  stroke  [10],  that  study  population  was  limited  to  in-
farcted  patients  and  the  sample  size  was  small,  thus  prompt-
ing  our  investigation.
1) Limitations of the study
This  study  is  subject  to  the  limitations  inherent  to  a  retro-
spective  non-randomized s t u d y  u s i n g  o b s e r v a t i o n a l  d a t a .  T h e  
small  number  of  patients  included  did  not  allow  for  adjust-
ments  for  differences  in  baseline  profiles  between  the  two 
groups.  Therefore,  perioperative  confounders,  procedural  bias, 
and  detection  bias  may  have  affected  our  results.  Another 
limitation was that only selected patients underwent follow-up 
MRI  or  CT.  Prospective  randomized  studies  including  larger 
patient  populations  are  therefore  required. 
CONCLUSION
Early  and  delayed  surgeries  for  IE  patients  with  acute  em-
bolic stroke were associated with similar clinical outcomes, as 
determined  by  mortality  and  neurologic  function.  Early  surgi-
cal intervention may be a valuable option for a subset of pa-
tients  at  high  risk  of  life-threatening  septic  embolism.
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